| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |